Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777192 · ClinicalTrials.gov registry record
Longitudinal Study of Symptoms in Colorectal Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 509
- Enrollment target
NCT00777192: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00777192 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777192 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 509 participants
- Enrollment target
Study Summary
The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
Interventions
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2008-08 |
| Est. Completion | 2018-12-27 |
Why NCT00777192 stopped before completion
NCT00777192 is an observational study that tracks outcomes without assigning an intervention. The registered 509 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT00777192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00777192 about?
NCT00777192 is a clinical study titled "Longitudinal Study of Symptoms in Colorectal Cancer". The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
What is the current status of trial NCT00777192?
This trial is currently terminated. The enrollment target is 509 participants. The study started on 2008-08. Estimated completion is 2018-12-27.
What interventions are being tested in trial NCT00777192?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00777192?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia